Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-05-25
DOI
10.1093/cid/ciab495
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody persistence in the first six months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study
- (2021) Arnaud G. L’Huillier et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months
- (2021) Aodhán Seán Breathnach et al. JOURNAL OF INFECTION
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters
- (2021) David De Ridder et al. Frontiers in Public Health
- Protection of healthcare workers against SARS-CoV-2 reinfection
- (2021) Chloé Dimeglio et al. CLINICAL INFECTIOUS DISEASES
- Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection
- (2021) Pauline Vetter et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020
- (2021) Anna Jeffery-Smith et al. Eurosurveillance
- Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
- (2021) Silvia Stringhini et al. LANCET INFECTIOUS DISEASES
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
- (2021) Rita E. Chen et al. NATURE MEDICINE
- Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
- (2021) Raymond A. Harvey et al. JAMA Internal Medicine
- COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough
- (2021) Rita Rubin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
- (2021) Christian Holm Hansen et al. LANCET
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
- (2021) Victoria Jane Hall et al. LANCET
- Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers
- (2021) Alice Berger et al. PLoS One
- Prolonged SARS‐CoV‐2 RNA shedding: Not a rare phenomenon
- (2020) Na Li et al. JOURNAL OF MEDICAL VIROLOGY
- Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
- (2020) Simon de Lusignan et al. LANCET INFECTIOUS DISEASES
- Validation of a commercially available SARS-CoV-2 serological immunoassay
- (2020) B. Meyer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
- (2020) Silvia Stringhini et al. LANCET
- What reinfections mean for COVID-19
- (2020) Akiko Iwasaki LANCET INFECTIOUS DISEASES
- Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
- (2020) Laith J Abu-Raddad et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
- (2020) Kristina L. Bajema et al. JAMA Internal Medicine
- One-to-many propensity score matching in cohort studies
- (2012) Jeremy A. Rassen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Statistical Criteria for Selecting the Optimal Number of Untreated Subjects Matched to Each Treated Subject When Using Many-to-One Matching on the Propensity Score
- (2010) Peter C. Austin AMERICAN JOURNAL OF EPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation